How is the SIBO test done?

The SIBO test is a non-invasive breath test used to detect excess bacteria in the small intestine by measuring gases produced when bacteria ferment specific sugars. This post explains what the SIBO test measures, why breath gas analysis works, differences between lactulose and glucose breath tests, step-by-step instructions for preparing and taking the test, and how clinicians interpret results. It also covers breath sample collection techniques, troubleshooting common pitfalls, and practical post-test steps including treatment and follow-up. Read on to learn how best to prepare for an accurate SIBO test and why choosing a reliable microbiome testing option matters.

Introduction to Gut Microbiome Testing and the Significance of the SIBO Test

The human gut microbiome is the collection of bacteria, archaea, viruses and fungi living primarily in the gastrointestinal tract. These microbial communities perform critical roles including digestion, nutrient synthesis, immune modulation, barrier protection and metabolic regulation. While diverse populations in the colon are normal and beneficial, the small intestine typically hosts a lower bacterial load. Small Intestinal Bacterial Overgrowth (SIBO) is a condition in which bacteria that normally belong in the colon, or an increased number of bacteria overall, become established in the small intestine. This displacement or overgrowth can compromise nutrient absorption, irritate the intestinal lining, cause fermentation of carbohydrates in the wrong location, and produce symptoms such as bloating, abdominal pain, excessive gas, diarrhea or constipation, nutrient deficiencies and systemic symptoms like fatigue. Accurate testing is vital because symptoms of SIBO overlap with many other conditions (irritable bowel syndrome, celiac disease, pancreatic insufficiency, and more), and treatments differ. Misdiagnosis can lead to unnecessary or ineffective therapies. From a clinical perspective, confirming SIBO helps clinicians choose targeted interventions such as antibiotic regimens, dietary strategies, prokinetics to improve motility, or underlying condition management. In research and personalized medicine, gut microbiome testing—including platforms like InnerBuddies’ microbiome test—helps paint a broader picture of gastrointestinal health and may guide adjunctive care decisions after SIBO is treated. Properly performed SIBO tests give objective data about abnormal bacterial activity in the small intestine, enabling evidence-based care, monitoring response to therapy, and reducing the risk of recurrence by directing follow-up strategies. In short, while gut microbiome testing provides population and diversity insights, the SIBO test specifically identifies abnormal bacterial fermentation in the small intestine—information that is central to managing a common but often underrecognized contributor to chronic gastrointestinal symptoms.

Understanding the SIBO Test: How It Detects Bacterial Overgrowth

The SIBO test primarily detects bacterial overgrowth by measuring gases produced when gut bacteria ferment carbohydrates that reach the small intestine. These gases—most commonly hydrogen (H2) and methane (CH4), and occasionally hydrogen sulfide (H2S)—are metabolic byproducts of microbial fermentation. The test uses a defined substrate (a sugar such as lactulose or glucose) that the patient ingests after a preparatory fast and dietary controls. If bacteria are present in abnormal numbers in the small intestine, they will ferment the substrate and produce gases earlier than would normally occur in the colon. Those gases diffuse across the intestinal wall, enter the bloodstream, travel to the lungs, and are exhaled. Collecting breath samples at regular intervals and analyzing gas concentrations over time creates a characteristic curve: an early rise in hydrogen or methane indicates fermentation in the small intestine (consistent with SIBO), whereas a later rise typically reflects fermentation in the colon, which is normal. The SIBO test therefore measures functional bacterial activity rather than counting organisms directly; it detects fermentation timing and intensity. This is a practical advantage because direct sampling of the small intestine (aspirate cultures) is invasive, expensive and technically challenging, and may miss patchy overgrowth. Breath testing is non-invasive, repeatable and accessible. Modern breath analyzers quantify parts per million (ppm) of hydrogen and methane, and some labs also report hydrogen sulfide when validated methods are available. Interpreting results requires attention to baselines, timing, and patient preparation: elevated baseline gases may indicate residual effects of recent food, supplements, or bacterial activity and can complicate interpretation. Likewise, methane-dominant patterns are associated with constipation-predominant presentations and may require different therapeutic choices. Understanding what the SIBO test measures—gas production from microbial fermentation in the small intestine—helps patients and clinicians apply the results appropriately, decide on further testing, and select treatments that target the underlying microbial imbalance and contributing factors such as motility dysfunction.

Gas Production Measurement: How Bacteria in the Small Intestine Are Quantified

Gas production measurement in SIBO testing is an indirect yet reliable method for quantifying bacterial activity in the small intestine. The principle is biochemical: bacteria metabolize carbohydrates anaerobically, producing gases as byproducts. Different microbes produce different gases—many fermenters produce hydrogen, some archaea consume hydrogen to generate methane, and other bacteria produce hydrogen sulfide. Breath testing quantifies the concentration of these gases in exhaled air at sequential time points after ingestion of a test substrate. The most common metrics are hydrogen in parts per million (ppm) and methane in ppm. Typical diagnostic thresholds involve an early rise in hydrogen of ≥20 ppm within 90 minutes or a methane concentration ≥10 ppm at any point, although specific criteria can vary by guideline and laboratory. These thresholds aim to distinguish small-intestinal fermentation from normal colonic fermentation, which occurs later. Gas dynamics are influenced by transit time: faster orocecal transit can cause earlier colonic fermentation and false positives; slow transit can delay colonic fermentation and mask overgrowth. Technologies used include handheld electrochemical sensors and laboratory-based gas chromatography systems; modern commercial analyzers combine portability with validated sensitivity and specificity. Sample collection typically uses breath collection tubes or bags, or direct sampling through a breath analyzer mouthpiece that measures gases in real time. Integrity of samples is paramount: contamination with room air, improper sealing of collection devices, or patient actions like smoking before the test can alter readings. Some newer testing protocols also analyze hydrogen sulfide using specialized electrodes or colorimetric assays, though H2S testing is less standardized clinically. Overall, gas measurements do not directly count bacterial colony-forming units but quantify metabolic activity that correlates with bacterial presence in the small intestine. When interpreted in clinical context—considering symptoms, medication history, and motility factors—gas production measurements provide actionable data. Laboratories and clinicians increasingly pair breath test data with broader microbiome tests (for example, a stool or comprehensive gut microbiome test such as the InnerBuddies microbiome test) to supplement diagnostic insight and guide personalized treatment plans targeting bacterial species, metabolic profiles, and dietary adjustments.

Lactulose vs Glucose Breath Test: Comparing Different Substrates Used in SIBO Diagnosis

Two primary substrates are used for SIBO breath testing: lactulose and glucose. Each interacts with the gut and resident microbes differently, which affects sensitivity, specificity and the clinical contexts in which they are preferred. Lactulose is a non-absorbable synthetic disaccharide that is not metabolized by human enzymes. When ingested, lactulose travels through the small intestine largely intact; if bacteria are present in the small intestine, they ferment lactulose and produce an early rise in breath hydrogen or methane. Because lactulose reaches the colon, colonic fermentation also occurs and produces a later gas peak—this biphasic pattern can help distinguish small intestine from colonic fermentation. Lactulose breath tests tend to be more sensitive to SIBO, potentially detecting overgrowth located farther along the small intestine. However, lactulose has lower specificity because rapid small-bowel transit or irritable bowel features can cause early colonic fermentation that mimics SIBO, leading to false positives. Glucose is a monosaccharide rapidly absorbed by the proximal small intestine. If bacterial overgrowth exists in the proximal small bowel, glucose is fermented before absorption and produces an early gas rise. Because glucose is absorbed quickly and doesn’t reach the distal small intestine or colon in significant amounts, glucose breath testing has higher specificity but lower sensitivity; it may miss bacterial overgrowth located beyond the proximal small intestine. Glucose testing is less likely to produce false positives from rapid transit but can produce false negatives for distal SIBO. Clinical selection depends on presentation: glucose may be preferable when proximal SIBO is suspected or when higher specificity is desired, while lactulose may be chosen if there’s a strong clinical suspicion and a desire to maximize sensitivity, recognizing possible travel of substrate to the colon. Other practical considerations include patient tolerance—lactulose can cause cramping and gas because it’s a fermentable sugar— and local lab protocols, availability of validated analysis methods for methane and hydrogen sulfide, and clinician familiarity with interpreting each substrate’s time-versus-ppm curves. In practice, some clinicians start with one test and repeat with the other if clinical suspicion remains high despite negative results. Combining breath test data with symptom patterns, transit studies, and microbiome profiling (for instance, supplementing with an InnerBuddies microbiome test to evaluate broader gut ecology) can provide a fuller diagnostic picture and reduce misclassification.

The SIBO Diagnostic Process: Step-by-Step Breakdown

The diagnostic journey for SIBO begins with an initial clinical evaluation in which a clinician takes a detailed history of gastrointestinal symptoms (bloating, gas, abdominal pain, diarrhea, constipation, unexplained weight loss, or nutrient deficiencies) and screening for red flags that may indicate alternate diagnoses (blood in stool, rapidly progressive symptoms, systemic signs). After evaluating risk factors (prior gastrointestinal surgery, structural abnormalities, motility disorders, chronic proton pump inhibitor use, immunodeficiency, or underlying diseases like scleroderma), the clinician decides whether breath testing is appropriate. If so, the next step is patient preparation: specific dietary restrictions and cessation of interfering medications for a set period before testing (more detail below). On test day, baseline breath samples are collected after fasting to establish pre-test gas levels. Then the chosen substrate (lactulose or glucose) is ingested in a measured dose. Serial breath samples are taken at standardized intervals—commonly every 15 to 20 minutes for 90 to 150 minutes depending on the protocol and substrate—using either direct analyzer mouthpieces or sampling collection tubes/bags. Samples are analyzed immediately or preserved for laboratory measurement of hydrogen, methane, and where available hydrogen sulfide. Clinicians interpret the gas rise timing and ppm thresholds in the context of the substrate used and the patient’s clinical picture. A positive test supports a diagnosis of SIBO, while a negative test does not absolutely rule it out—clinical judgment matters. After results are available, the clinician discusses treatment options tailored to the gas profile (hydrogen-dominant vs methane-dominant infections often require different therapeutic approaches), symptom pattern and underlying causes. Typical treatments include antibiotics or antimicrobial herbal regimens, dietary modifications (low FODMAP or specific carbohydrate approaches), motility agents, probiotics with caution depending on pattern, and correction of underlying factors such as obstruction or hypochlorhydria. Follow-up may include symptom tracking and repeat breath testing after treatment to confirm eradication, or broader microbiome testing (e.g., a gut microbiome test like the one offered by InnerBuddies) to monitor ecosystem changes and guide longer-term gut health strategies. Throughout the diagnostic process, clear communication about preparation, limitations, and expected outcomes is essential to maximize the diagnostic value of the SIBO test.

Breath Sample Collection: The Key to Accurate SIBO Detection

Collecting reliable breath samples is foundational to accurate SIBO diagnosis. The collection technique influences baseline measurements, the shape of the gas curve, and ultimately whether results are considered valid. Breath samples are typically collected either directly into an analyzer using a mouthpiece with real-time sensors or into sealed sample bags or tubes that are analyzed in a lab. Best practices include instructing patients to avoid smoking, chewing gum, or vigorous exercise before testing as these behaviors can alter baseline gas levels. On the test day, patients must rinse their mouth with water (without toothpaste) before baseline sampling; toothpaste residues and mouth microbial fermentation can artificially raise hydrogen readings. Baseline samples establish whether there is already elevated gas production that may invalidate the test or require repeat testing after improved preparation. After ingesting the substrate, serial sampling every 15–20 minutes captures the temporal dynamics of gas production. It is critical that patients follow instructions to exhale fully into the collection device and avoid talking or breathing through the nose during sample capture, as incomplete exhalations lead to diluted samples. For tube-based collection, proper sealing and labeling are essential to prevent contamination and mix-ups. Environmental contamination (e.g., a high ambient methane environment) can also affect readings if the device does not correct for ambient air. Common challenges include incomplete fasting, recent smoking, or failure to stop certain medications that can suppress or alter microbial activity (antibiotics, certain probiotics, or promotility agents). To troubleshoot, clinicians may review preparation adherence, assess baseline gas levels, and when necessary repeat the test after correcting preparation issues. Increasingly, remote or home breath test kits provide clear step-by-step instructions and pre-labeled collection tubes, enabling high-quality samples without clinic visits; however, users must carefully follow directions for timing, mouth rinsing, and storage before shipping samples back to the laboratory. Whether in a clinic or at home, ensuring sample integrity—adequate exhalation, correct timing, secure storage, and avoidance of contaminants—maximizes the clinical utility of the SIBO breath test results and reduces the need for repeat testing.

SIBO Testing Preparation: How to Get Ready for Accurate Results

Proper preparation is one of the most important determinants of an accurate SIBO breath test. Patients typically begin preparation 24–48 hours before testing with a simplified diet that minimizes fermentable carbohydrates; many protocols recommend a low-residue or low-fiber diet for 24 hours and avoidance of high-FODMAP foods (fermentable oligo-, di-, mono-saccharides and polyols) in the immediate pre-test window. The purpose is to reduce baseline gas production and clear fermentable substrates from the small intestine so that the test substrate’s fermentation can be measured cleanly. Common recommended foods include plain white rice, lean protein, eggs, clear broths, and non-fermentable vegetables such as peeled cucumbers or lettuce; dairy, high-fiber grains, beans, and many fruits should be avoided. Patients must fast for 8–12 hours before the test, allowing only water which should be stopped about an hour before baseline sampling. Certain medications and supplements interfere with breath test results and should be stopped under clinician guidance: antibiotics and probiotic supplements should be discontinued for at least two to four weeks when possible because they significantly alter gut flora; prokinetic agents and laxatives may need to be stopped several days prior; promotility drugs and certain antacids or H2 blockers can also influence results, and proton pump inhibitors—associated with SIBO risk—are often discussed with the clinician regarding whether and how to pause them before testing. Smoking and vigorous exercise should be avoided for at least 12–24 hours as they may alter baseline readings. Good hydration is acceptable, but chewing gum and mints should be avoided as they stimulate saliva and may bring fermentable residues into the small intestine. The specifics of dietary exclusion and medication washout are tailored to the patient’s clinical situation by the ordering clinician; in some instances, temporary cessation of essential medications is not safe, and testing proceeds with caution or alternative diagnostic strategies are considered. Following instructions carefully reduces false positives and negatives: false positives can occur when leftover dietary carbohydrates are fermented early, while false negatives may arise from recent antibiotics or suppression of gas-producers. Clear pre-test instructions, ideally in written form, and clinician availability to address patient questions improve adherence and test validity. For patients seeking an overall view of gut health beyond SIBO, combining breath testing with a comprehensive gut microbiome analysis (for example, an at-home microbiome test available through InnerBuddies) can inform broader dietary and therapeutic decisions while respecting pre-test constraints for breath testing.

Post-Test Procedures and Interpreting Results

After breath samples are collected, analysis quantifies hydrogen, methane and—when available—hydrogen sulfide concentrations at each time point and generates a time-versus-gas profile. Laboratories compare these values to established thresholds and patterns to classify tests as positive, negative, or indeterminate. For hydrogen, a standard interpretation across many labs is a rise of ≥20 ppm above baseline within 90 minutes (exact times vary by protocol). Methane is often interpreted differently because some patients have a baseline methane elevation; any methane level ≥10 ppm at any time during testing may be considered clinically relevant because methane-producing archaea are associated with constipation-predominant symptoms and different therapeutic approaches. It's important that clinicians interpret results in the context of symptom history, baseline levels, and the substrate used. A positive result typically leads to a treatment plan targeted to the gas profile: hydrogen-dominant SIBO frequently responds to specific oral antibiotics (e.g., rifaximin in many protocols) or to herbal antimicrobial regimens, while methane-dominant SIBO may require combination therapy that targets archaea (such as rifaximin paired with neomycin in some studies) or tailored herbal combinations. Dietary strategies—low FODMAP or targeted carbohydrate restriction—are often used adjunctively to reduce fermentable substrate availability while antibiotics or other measures reduce microbial load. Motility support with prokinetics can help address recurrence risk by improving small bowel clearance. Follow-up testing is commonly performed 4–12 weeks after therapy to assess eradication; however, clinical symptom improvement is often the primary outcome used to judge success, and repeat breath testing may be reserved for persistent or recurrent symptoms. For indeterminate or borderline results, clinicians might repeat the breath test after verifying preparation adherence or perform additional evaluations such as small bowel imaging, comprehensive microbiome testing (with products like the InnerBuddies microbiome test to evaluate stool microbial composition and metabolic markers), or referral to gastroenterology for specialized assessment including, in rare cases, small bowel aspirate and culture. Patient counseling about recurrence risk and triggers, coupled with strategies to restore and maintain healthy gut ecology—including nutrition, resolving underlying motility issues, and cautious use of probiotics—is critical to long-term management.

Conclusion: The Importance of Proper SIBO Testing for Gut Health

SIBO testing via breath analysis is a clinically valuable, non-invasive tool that detects bacterial fermentation in the small intestine by measuring exhaled gases. Accurate diagnosis hinges on appropriate patient selection, meticulous preparation, standardized sample collection, and careful interpretation of hydrogen, methane and, where available, hydrogen sulfide profiles relative to the chosen substrate. Differentiating between lactulose and glucose breath tests helps tailor testing to the clinical scenario, balancing sensitivity and specificity. Once diagnosed, targeted treatment strategies informed by gas profiles and combined with lifestyle and motility interventions yield the best outcomes and reduce recurrence risk. Because the gut microbiome is complex and interconnected, clinicians and patients may also find value in broader microbiome testing—like a gut microbiome test from InnerBuddies—to complement breath testing, guide dietary choices, and measure ecosystem changes over time. Using validated testing methodologies and following evidence-based preparation and interpretation protocols ensures that SIBO testing provides actionable data, improves diagnostic clarity for overlapping gastrointestinal disorders, and supports personalized treatment strategies that restore digestive function and enhance overall health. If you suspect SIBO, discuss testing options with a qualified healthcare professional who can evaluate your individual risk factors, recommend the appropriate test and substrate, and create a follow-up plan that includes symptom monitoring and possible repeat testing to confirm successful treatment.

References and Resources for Further Information

For readers seeking further information and practical testing options, it is helpful to consult reputable sources and validated at-home testing products. InnerBuddies provides at-home gut microbiome testing kits that can augment clinical breath testing by offering a broader view of stool microbial composition and functional markers; for those interested, the InnerBuddies Microbiome Test is available for purchase online and can complement SIBO evaluation by identifying patterns in gut ecology that may influence recurrence or therapeutic response (InnerBuddies microbiome test). Many clinicians use breath testing in concert with stool-based microbiome assays to obtain both functional and compositional data—breath tests reveal active small-intestinal fermentation while stool tests characterize colonic communities and potential dysbiosis. When choosing testing services, prioritize laboratories with validated protocols for hydrogen and methane measurement, standardized time-point collections, clear patient preparation instructions, and clinical support for interpreting results. InnerBuddies' testing resources include guidance and context for interpreting microbiome profiles and practical recommendations that align with clinical care pathways; see their product page for an at-home testing option that can be ordered directly (purchase the InnerBuddies microbiome test). For clinicians and patients alike, using coordinated testing approaches—clinical evaluation, breath testing for SIBO, and a complementary gut microbiome assessment—supports a more comprehensive understanding of gastrointestinal health and can guide targeted, personalized interventions.

Q&A: Key Questions and Answers About the SIBO Test

Q: What exactly does a SIBO breath test measure? A: The SIBO breath test measures gases—principally hydrogen and methane—produced by microbial fermentation of an ingested substrate (lactulose or glucose). These gases are absorbed into the bloodstream and exhaled, allowing indirect assessment of small-intestinal bacterial activity. Q: How should I prepare for the test? A: Follow your clinician’s instructions: typically avoid fermentable foods (a low-residue or low-FODMAP diet) for 24–48 hours, fast for 8–12 hours prior, stop certain medications like antibiotics for at least two to four weeks if safe, and avoid smoking and exercise before the test. Mouth rinsing before baseline sampling is often required. Q: Which is better, lactulose or glucose breath test? A: It depends. Lactulose is more sensitive but less specific and can detect distal small intestinal overgrowth; glucose is more specific but may miss distal SIBO because it’s absorbed in the proximal small bowel. Clinicians choose based on clinical suspicion and patient factors. Q: What do hydrogen- vs methane-dominant results mean? A: Hydrogen-dominant patterns are often associated with diarrhea and rapid fermentation, while methane-dominant patterns are frequently linked to constipation and indicate methanogenic archaea, which may require different therapies. Q: Can a negative test rule out SIBO? A: Not absolutely. False negatives can occur with recent antibiotics, low bacterial activity, or distal overgrowth missed by glucose testing. Clinical judgment and sometimes repeat or alternate-substrate testing are needed. Q: How are results used for treatment? A: Positive tests lead to targeted therapies—antibiotics or herbal antimicrobials, dietary adjustments, prokinetics, and strategies to correct underlying causes. Follow-up testing and broader microbiome assessments (for example, via an at-home microbiome test) can monitor treatment response and guide maintenance strategies. Q: Are at-home testing options reliable? A: Many at-home test kits use validated lab analysis; however, sample collection and adherence to preparatory instructions are crucial. Combining breath testing with validated at-home gut microbiome tests, such as InnerBuddies’ offerings, can provide complementary information for clinicians and patients planning long-term gut health strategies (InnerBuddies microbiome test). Q: When should I see a specialist? A: If symptoms are severe, progressive, or accompanied by red flags (weight loss, bleeding, high fever), or if initial testing is inconclusive despite ongoing symptoms, referral to a gastroenterologist is appropriate.

Important Keywords

SIBO test, small intestinal bacterial overgrowth, breath test, hydrogen breath test, methane breath test, lactulose breath test, glucose breath test, hydrogen sulfide, gut microbiome test, InnerBuddies microbiome test, at-home microbiome testing, breath sample collection, SIBO preparation, gut dysbiosis, SIBO treatment, antibiotic therapy, herbal antimicrobials, motility agents, low FODMAP diet, diagnostic thresholds, clinical interpretation, hydrogen ppm, methane ppm, digestive health, gastrointestinal testing, personalized gut health.